Zacks Research Has Negative Outlook for COO FY2026 Earnings

Key Points

• Zacks Research cut Cooper Companies’ FY2026 earnings estimate to $4.53 per share from $4.61 and maintained a “Strong Sell” rating. The revised forecast aligns with the company’s FY2026 guidance of $4.51–$4.55 per share.
• Analyst sentiment has weakened, with multiple brokerages lowering price targets or downgrading the stock; the overall consensus is now “Hold,” with an average price target of $71.47.
• Cooper Companies authorized a $3 billion share buyback, allowing repurchases of up to 22.7% of outstanding shares. Directors also made significant recent purchases, while the stock traded near $57.41, well below its 52-week high of $89.83.

The Cooper Companies, Inc. (NASDAQ:COO - Free Report) - Investment analysts at Zacks Research decreased their FY2026 earnings estimates for shares of Cooper Companies in a report issued on Tuesday, September 29th. Zacks Research analyst Team now forecasts that the medical device company will earn $4.53 per share for the year, down from their prior estimate of $4.61. Zacks Research has a "Strong Sell" rating on the stock. The consensus estimate for Cooper Companies' current full-year earnings is $4.53 per share. Zacks Research also issued estimates for Cooper Companies' Q4 2026 earnings at $1.07 EPS, Q1 2027 earnings at $1.10 EPS, Q2 2027 earnings at $1.17 EPS, Q3 2027 earnings at $1.18 EPS, Q4 2027 earnings at $1.25 EPS, FY2027 earnings at $4.70 EPS, Q1 2028 earnings at $1.23 EPS, Q2 2028 earnings at $1.28 EPS, Q3 2028 earnings at $1.29 EPS and FY2028 earnings at $5.19 EPS.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share for the quarter, topping analysts' consensus estimates of $1.12 by $0.03. The business had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.10 billion. Cooper Companies had a net margin of 13.46% and a return on equity of 10.90%. Cooper Companies's revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.49 earnings per share. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS.

Several other brokerages also recently issued reports on COO. Wall Street Zen downgraded Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, September 12th. Needham & Company LLC lowered their target price on shares of Cooper Companies from $86.00 to $73.00 and set a "buy" rating on the stock in a report on Thursday, September 10th. Piper Sandler cut Cooper Companies from an "overweight" rating to a "neutral" rating and dropped their price target for the company from $86.00 to $59.00 in a research note on Thursday, September 10th. Wells Fargo & Company set a $61.00 price target on shares of Cooper Companies and gave the company an "equal weight" rating in a report on Thursday, September 10th. Finally, UBS Group reduced their target price on shares of Cooper Companies from $75.00 to $66.00 and set a "neutral" rating for the company in a research report on Thursday, September 10th. Five analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $71.47.

Cooper Companies Trading Up 1.6%

NASDAQ:COO opened at $57.41 on Friday. The firm has a market capitalization of $10.92 billion, a price-to-earnings ratio of 19.59, a PEG ratio of 2.30 and a beta of 0.83. The business's 50-day moving average price is $67.22 and its two-hundred day moving average price is $67.27. The company has a current ratio of 1.22, a quick ratio of 0.73 and a debt-to-equity ratio of 0.23. Cooper Companies has a 1-year low of $51.01 and a 1-year high of $89.83.

Cooper Companies announced that its board has approved a share buyback plan on Wednesday, September 9th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the medical device company to repurchase up to 22.7% of its stock through open market purchases. Stock buyback plans are often a sign that the company's leadership believes its stock is undervalued.

Insider Activity

In other news, Director Paul Keel purchased 4,701 shares of Cooper Companies stock in a transaction dated Friday, September 11th. The shares were bought at an average cost of $53.18 per share, for a total transaction of $249,999.18. Following the completion of the acquisition, the director owned 4,701 shares in the company, valued at approximately $249,999.18. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Lawrence Kurzius acquired 10,000 shares of the stock in a transaction dated Wednesday, September 16th. The stock was purchased at an average cost of $54.93 per share, with a total value of $549,300.00. Following the purchase, the director directly owned 31,099 shares of the company's stock, valued at $1,708,268.07. This trade represents a 47.40% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders have bought 34,701 shares of company stock valued at $1,880,039. 2.08% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Cooper Companies

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Algert Global LLC bought a new position in Cooper Companies in the 2nd quarter worth about $7,655,000. Bank of America Corp DE purchased a new stake in shares of Cooper Companies in the 2nd quarter valued at $144,125,000. BlackRock Inc. purchased a new position in shares of Cooper Companies in the second quarter worth about $1,077,762,000. Heartland Advisors Inc. bought a new stake in Cooper Companies in the fourth quarter valued at approximately $15,348,000. Finally, National Pension Service boosted its stake in shares of Cooper Companies by 9,314.0% during the second quarter. National Pension Service now owns 526,149 shares of the medical device company's stock valued at $37,730,000 after purchasing an additional 520,560 shares during the period. Institutional investors and hedge funds own 24.39% of the company's stock.

Trending Headlines about Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Neutral Sentiment: There is no clearly positive company-specific announcement in the latest reports. Investors may be treating the recent decline as an opportunity to buy after concerns about inventory and earnings growth were already reflected in the stock.

About Cooper Companies

CooperCompanies NASDAQ: COO is a global medical device company focused on improving vision and advancing women's health. Its operations are organized primarily through CooperVision and CooperSurgical, which develop, manufacture and distribute products for eye care, fertility and other areas of reproductive health.

CooperVision offers a broad range of contact lenses, including lenses for nearsightedness, farsightedness, astigmatism and presbyopia. Its portfolio includes daily disposable, reusable and specialty lenses, as well as products designed to address the progression of myopia in children and adolescents.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.